Authors:
GUASTALLA JP
FERRERO JM
BENBUNAN JL
KANOUI A
GAUTIER H
VINCENT P
DARSE T
CASTERA D
JACQUIN JP
CRETIN J
BOUTANLAROZE A
BICHOFFE A
GOUTTEBEL MC
PUJADELAURAINE E
Citation: Jp. Guastalla et al., TOPOTECAN(T) FOLLOWED BY ETOPOSIDE (E) IN PRETREATED OVARIAN-CANCER (OC) PATIENTS (PTS) - A GINECO PHASE-II STUDY, Annals of oncology, 9, 1998, pp. 320-320
Authors:
VINCENT P
GUASTALLA JP
PIEDBOIS P
WEBER B
GANEM G
CURE H
TRILLETLENOIR V
GOUPIL A
MIGNOT L
PUJADELAURAINE E
Citation: P. Vincent et al., TAXOL(R) (T) PLUS CARBOPLATIN (CB) IN PRETREATED OVARIAN-CANCER (OC) PATIENTS (PTS) - A RANDOMIZED COMPARISON OF 2 CARBOPLATIN DOSE CALCULATIONS (AUC VS BSA), Annals of oncology, 9, 1998, pp. 323-323
Authors:
GUASTALLA JP
PUJADELAURAINE E
WEBER B
CURE H
ORFEUVRE H
MOUSSEAU M
VINCENT P
DIERAS V
TUBIANAMATHIEU N
JACQUIN JP
MIGNOT L
LEDUC B
VIENS P
PARISO D
Citation: Jp. Guastalla et al., EFFICACY AND SAFETY OF THE PACLITAXEL AND CARBOPLATIN COMBINATION IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED OVARIAN-CARCINOMA - A MULTICENTER GINECO ATEURS-NATIONAUX-POUR-LETUDE-DES-CANCERS-OVARIENS) PHASE-II STUDY, Annals of oncology, 9(1), 1998, pp. 37-43
Authors:
BEHAR A
PUJADELAURAINE E
MAUREL A
BRUN MD
LAGRUE G
DECHAUVIN FF
OULIDAISSA D
HILLE D
Citation: A. Behar et al., THE PATHOPHYSIOLOGICAL MECHANISM OF FLUID RETENTION IN ADVANCED CANCER-PATIENTS TREATED WITH DOCETAXEL, BUT NOT RECEIVING CORTICOSTEROID COMEDICATION, British journal of clinical pharmacology, 43(6), 1997, pp. 653-658
Authors:
PUJADELAURAINE E
GUASTALLA JP
WEBER B
CURE H
ORFEUVRE H
MOUSSEAU M
VINCENT P
DIERAS V
TUBIANAMATHIEU N
JACQUIN JP
MIGNOT L
LEDUC B
PARAISO D
VIENS P
Citation: E. Pujadelauraine et al., EFFICACY AND SAFETY OF THE COMBINATION PACLITAXEL CARBOPLATIN IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED OVARIAN-CARCINOMA - A MULTICENTER FRENCH GATEURS-NATIONAUX-POUR-LETUDE-DES-CANCERS-OVARIENS PHASE-II STUDY/, Seminars in oncology, 24(5), 1997, pp. 30-35
Authors:
MIRSHAHI SS
LOUNES KC
LU H
PUJADELAURAINE E
MISHAL Z
BENARD J
BERNADOU A
SORIA C
SORIA J
Citation: Ss. Mirshahi et al., DEFECTIVE CELL-MIGRATION IN AN OVARIAN-CANCER CELL-LINE IS ASSOCIATEDWITH IMPAIRED UROKINASE-INDUCED TYROSINE PHOSPHORYLATION, FEBS letters, 411(2-3), 1997, pp. 322-326
Authors:
TOURANI JM
GRISE P
LUCAS V
MAYEUR D
DUFOUR B
DIPALMA M
BOAZIZ C
PAVLOVITCH JM
PUJADELAURAINE E
LARREGAIN D
UNTEREINER M
Citation: Jm. Tourani et al., INTERLEUKIN-2 IN OUTPATIENTS WITH RENAL-CELL CARCINOMA - SCAPP1 TRIAL, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(5), 1996, pp. 297-300
Authors:
TOURANI JM
LUCAS V
MAYEUR D
DUFOUR B
DIPALMA M
BOAZIZ C
GRISE P
VARETTE C
PAVLOVITCH JM
PUJADELAURAINE E
LARREGAIN D
ECSTEIN E
UNTEREINER M
VUILLEMIN E
MERRAN S
ANDRIEU JM
Citation: Jm. Tourani et al., SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 (RIL-2) IN OUT-PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA - RESULTS OF A MULTICENTER SCAPP1 TRIAL, Annals of oncology, 7(5), 1996, pp. 525-528
Authors:
PUJADELAURAINE E
GUASTALLA JP
COLOMBO N
DEVILLIER P
FRANCOIS E
FUMOLEAU P
MONNIER A
NOOY M
MIGNOT L
BUGAT R
MARQUES C
MOUSSEAU M
NETTER G
MALOISEL F
LARBAOUI S
BRANDELY M
Citation: E. Pujadelauraine et al., INTRAPERITONEAL RECOMBINANT INTERFERON-GAMMA IN OVARIAN-CANCER PATIENTS WITH RESIDUAL DISEASE AT 2ND-LOOK LAPAROTOMY, Journal of clinical oncology, 14(2), 1996, pp. 343-350
Authors:
BATELCOPEL L
MOMMEJAMARIN H
OUDARD S
CHAUVENET L
PUJADELAURAINE E
COUPIER J
BERNADOU A
Citation: L. Batelcopel et al., ANAPHYLACTIC REACTION AFTER A FIRST FILGRASTIM (GRANULOCYTE-COLONY-STIMULATING FACTOR) INJECTION, European journal of cancer, 31A(13-14), 1995, pp. 2428-2428
Citation: Jm. Rodier et E. Pujadelauraine, AUTOCRINE STIMULATION OF COLONIC-CARCINOM A CELL-PROLIFERATION - BIOLOGICAL ANECDOTE OR NEW THERAPEUTIC TARGET, Bulletin du cancer, 82(4), 1995, pp. 292-295